Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Endocrinol Metab (Seoul). 2024 Apr;39(2):364-374. doi: 10.3803/EnM.2023.1878. Epub 2024 Mar 21.
This study evaluated the effects of a mobile diabetes management program called "iCareD" (College of Medicine, The Catholic University of Korea) which was integrated into the hospital's electronic medical records system to minimize the workload of the healthcare team in the real clinical practice setting.
In this retrospective observational study, we recruited 308 patients. We categorized these patients based on their compliance regarding their use of the iCareD program at home; compliance was determined through self-monitored blood glucose inputs and message subscription rates. We analyzed changes in the ABC (hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol) levels from the baseline to 12 months thereafter, based on the patients' iCareD usage patterns.
The patients comprised 92 (30%) non-users, 170 (55%) poor-compliance users, and 46 (15%) good-compliance users; the ABC target achievement rate showed prominent changes in good-compliance groups from baseline to 12 months (10.9% vs. 23.9%, P<0.05), whereas no significant changes were observed for poor-compliance users and non-users (13.5% vs. 18.8%, P=0.106; 20.7% vs. 14.1%, P=0.201; respectively).
Implementing the iCareD can improve the ABC levels of patients with diabetes with minimal efforts of the healthcare team in real clinical settings. However, the improvement of patients' compliance concerning the use of the system without the vigorous intervention of the healthcare team needs to be solved in the future.
本研究评估了一种名为“iCareD”的移动糖尿病管理程序的效果(韩国天主教大学医学院),该程序整合到医院的电子病历系统中,以最大限度地减少医疗团队在实际临床实践中的工作量。
在这项回顾性观察研究中,我们招募了 308 名患者。我们根据他们在家中使用 iCareD 程序的依从性对这些患者进行分类;通过自我监测的血糖输入和消息订阅率来确定依从性。我们根据患者的 iCareD 使用模式,分析从基线到 12 个月后 ABC(糖化血红蛋白、血压和低密度脂蛋白胆固醇)水平的变化。
患者包括 92 名(30%)非使用者、170 名(55%)低依从性使用者和 46 名(15%)高依从性使用者;从基线到 12 个月,高依从性组的 ABC 达标率有显著变化(10.9%比 23.9%,P<0.05),而低依从性组和非使用者组无显著变化(13.5%比 18.8%,P=0.106;20.7%比 14.1%,P=0.201)。
在真实临床环境中,实施 iCareD 可以改善糖尿病患者的 ABC 水平,而无需医疗团队付出过多努力。然而,未来需要解决患者在没有医疗团队大力干预的情况下使用系统的依从性提高的问题。